Clinical Research in HIV, AIDS and Prevention
A peer-reviewed, open-access journal advancing HIV treatment, prevention and global care — across virology, antiretroviral therapy, epidemiology and public health.
The scope of the journal
JCRHAP publishes original research, reviews, case reports and short communications across the full arc of HIV science. Manuscripts are welcomed in any of the following areas.
HIV treatment & clinical care
- Antiretroviral therapy & regimen optimisation
- Adherence, retention and PrEP delivery
- Comorbidities, aging and long-term care
Prevention science
- Biomedical & behavioural prevention
- HIV testing, diagnostics and linkage
- Community and structural interventions
Epidemiology & public health
- Surveillance and risk epidemiology
- Health disparities and key populations
- Global HIV care, policy and implementation
Virology & immunology
- Pathogenesis and immune response
- Drug resistance and viral dynamics
- Translational and basic HIV science
Editorial oversight
Manuscripts are handled by clinicians and researchers across HIV medicine, immunology, epidemiology and prevention science. Selected members of the board:
From the journal
Recent peer-reviewed studies from across the HIV prevention and care continuum, freely available to read.
-
Assessment of Syndemic Inter-relationships between Substance Use, Violence and HIV Risk Among Persons Seeking Emergency Care in Nairobi, Kenya
-
Recruitment Strategies and Challenges in a Pilot HIV Prevention Study among Cisgender Black Women in Houston, Texas
-
HIV-Associated Peripheral Neuropathy and Antiretroviral Therapy: A Prospective Study from a Tertiary Care Centre in South India
-
Factors Influencing HIV Status Disclosure Among People Living with HIV/AIDS in Mukono District, Uganda: Beyond Health System Support
-
Human Immunodeficiency Virus Drug Resistance (HIVDR) and Baseline Characteristics among Antiretroviral Therapy (ART) experienced Children and Adolescents under the care of Chidamoyo Christian Hospital in Hurungwe, Zimbabwe
-
Barriers and Opportunities to Improve the Implementation of Patient Screening and Linkage to Pre-Exposure Prophylaxis in Primary Care
Information for authors
- Peer review
- Single-blind (double-blind on request). Every submission is assessed on scientific merit by expert reviewers.
- Article-processing charge
- USD 2,100, payable only on acceptance. There is no submission fee.
- Open access & licensing
- Articles are published open access and free to read worldwide. DOI registration status is displayed in the journal archive.
- Submission
- Authors may submit through ManuscriptZone or the JCRHAP-specific submission form. ManuscriptZone is the primary platform for managing the full editorial workflow.
Authors are expected to meet recognized standards for authorship, originality and the declaration of any competing interests. Full requirements, including formatting and ethics policies, are set out in the author instructions.
Publishing with JCRHAP
Global open-access reach
Every article is free to read worldwide from the day of publication, supporting clinical, public-health and research use.
A permanent, citable record
Published articles are assigned Crossref DOIs, with registration status displayed in the journal archive.
Rigorous, fair review
Single-blind peer review (double-blind on request), judged solely on scientific merit.
An international board
14 years of publishing, guided by clinicians and researchers with HIV-related expertise.
Submit your research to JCRHAP
Contribute to 14 years of open-access HIV, AIDS and prevention science, reviewed on merit and free to read worldwide.
Frequently asked
What does JCRHAP publish?
Original research, reviews, case reports and short communications across HIV clinical research, AIDS prevention and PrEP, epidemiology, antiretroviral therapy, virology and immunology, public health, behavioral science, testing, adherence, comorbidities and global HIV care.
Is the journal open access, and what does it cost?
Yes. Every article is fully open access and free to read worldwide. The article-processing charge is USD 2,100, payable only on acceptance. There is no submission fee.
What type of peer review does JCRHAP use?
Single-blind (double-blind on request). Every submission is evaluated on scientific merit by expert reviewers.
How do I submit my manuscript?
Authors may submit through ManuscriptZone or the JCRHAP-specific submission form. ManuscriptZone is the primary platform for managing the full editorial workflow.
Are articles assigned a DOI?
Published articles are assigned Crossref DOIs, with registration status displayed in the journal archive.
Who is the journal for?
Clinicians, infectious-disease specialists, epidemiologists, virologists, immunologists, public-health and behavioral researchers, policymakers, reviewers and prospective authors working across HIV treatment, prevention and care.